1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar : October 19 - October 25, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar : October 19 - October 25, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs
Event Date: 10/21/2025
Location: Arlington, VA
Subject: Public Health Policy
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Association of State and Territorial Health Officials (ASTHO) leadership and representatives

Event Date: 10/21/2025
Location: Silver Spring, MD
Subject: Collaborative Roundtable Discussion
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Rare Disease Company Coalition (RDCC) representatives

Event Date: 10/21/2025
Location: Silver Spring, MD
Subject: Areas of Collaboration and Other Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: American Pharmacists Association (APhA) leadership

Event Date: 10/22/2025
Location: Washington, DC
Subject: National Academy of Medicine (NAM), Improving Resiliency in the U.S. Pharmaceutical Supply Chain Through Make-Buy-Invest Strategic Actions Workshop
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: National Academy of Medicine representatives

Event Date: 10/24/2025
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA stafff
Non FDA Participant/Group: Senator Jim Banks, (R-IN)

Event Date: 10/25/2025
Location: Washington, DC
Subject: Stand Together Frederick Douglass Society Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Stand Together leadership

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs
No Significant Event

Official Name: Sean R. Keveney, Chief Counsel
No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods
No Significant Event

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations
No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations
No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research
No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
No Significant Event

Official Name: George F. Tidmarsh, M.D., Ph.D., Director, Center for Drug Evaluation and Research
No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products
No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine
Event Date: 10/22/2025
Location: College Park, MD
Subject: Animal Health Institute (AHI) Triannual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Animal Health Institute (AHI) representatives

Event Date: 10/23/2025
Location: College Park, MD
Subject: Generic Animal Drug Alliance (GADA) Triannual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Generic Animal Drug Alliance (GADA) representatives

Back to Top